Bausch Health Companies Inc. Debt Instrument, Face Amount
Bausch Health Companies Inc. (BHC) had Debt Instrument, Face Amount of $9.56 billion as of 2017-12-31, per its 8-K filed 2018-08-10.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2018-08-10
- 2017-12-31: Debt Instrument, Face Amount $9.56B.
- 2017-09-30: Debt Instrument, Face Amount $6.31B.
- 2017-06-30: Debt Instrument, Face Amount $6.31B.
- 2017-03-31: Debt Instrument, Face Amount $6.31B.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2017-12-31 | $9.56B 8-K · filed 2018-08-10 |
| 2017-09-30 | $6.31B 10-Q · filed 2017-11-07 |
| 2017-06-30 | $6.31B 10-Q · filed 2017-08-08 |
| 2017-03-31 | $6.31B 10-Q · filed 2017-05-09 |
| 2013-06-27 | $4.05B 10-Q · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |